Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: A potential mechanism for increased atherogenicity

Journal of Lipid Research

Volumn 39, Issue 6, 1998, Pages 1263-1273

  Galeano, Narmer F ^a   Al Haideri, Maysoon ^a   Keyserman, Fannie ^a   Rumsey, Steven C ^a   Deckelbaum, Richard J ^a  

^a Columbia University ^*  (United States)

Author keywords

Apolipoprorein B; Atherosclerosis; Lipoproteins; Proteoglycans

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPOPROTEIN METABOLISM; PARTICLE SIZE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY;

APOLIPOPROTEINS B; BINDING SITES; CELL LINE; CELL MEMBRANE; CHOLESTEROL; CHOLESTEROL ESTERS; FIBROBLASTS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS, LDL; PHOSPHOLIPIDS; PROTEIN CONFORMATION; RECEPTORS, LDL; SKIN; TRIGLYCERIDES;

EID: 0031809817     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (81)

1. Castelli, W. P., P. W. F. Wilson, D. Levy, and K. Anderson. 1990. Serum lipid and risk of coronary artery disease. Atheroscler. Rev. 21: 7-19.
2. Brown, M. S., and J. L. Goldslein. 1986. A receptor mediated pathway for cholesterol homeostasis. Science. 232: 232-246.
3. Shepherd, J., and C. J. Packard. 1986. Receptor-independent low-density lipoprotein catabolism. Methods Enzymol. 129: 566-590.
4. Spady, D. K., L. A. Woollett, and J. M. Dietschy. 1993. Regulation of plasma LDL cholesterol levels by dietary cholesterol and fatty acids. Annu. Rev. Nutr. 13: 355-381.
5. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
6. Goldstein, J. L., and M. S. Brown. 1977. Atherosclerosis: the low density lipoprotein receptor hypothesis. Metabolism. 26: 1257-1275.
7. Goldstein, J. L., and M. S. Brown. 1974. Binding and degradation of low density lipoproteins by cultured human fibroblasts. J. Biol. Chem. 249: 5153-5162.
8. Fogelman, A. M., M. E. Haberland, and P. A. Edwards. 1986. Uptake of low density lipoproteins by lower-affinity processes. Atheroscler. Rev. 14: 110-117.
9. Krauss, R. M., and D. J. Burke. 1982. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J. Lipid Res. 23: 97-104.
10. Shen, M. M. S., R. M. Krauss, F. T. Lindgren, and T. M. Forte. 1981. Heterogeniety of serum low density lipoproteins in normal human subjects. J. Lipid Res. 22: 236-244.
11. Tikkanen, M. J., T. G. Cole, and G. Schonfeld. 1983. Differential reactivity of human low density lipoproteins with monoclonal antibodies. J. Lipid Res. 24: 1494-1499.
12. Teng, B., G. R. Thompson, A. D. Sniderman, T. M. Forte, R. M. Krauss and P. O. Kwiterovitch. 1985. Modulation of apolipoprotein B antigenic determinants in human low density lipoproteins. J. Biol. Chem. 260: 5067-5072.
13. Deckelbaum, R. J., E. Granot, Y. Oschry, L. Rose, and S. Eisenberg. 1984. Plasma triglycerides determine structure composition in low and high density lipoproteins. Arteriosclerosis. 4: 220-231.
14. Austin M. A., J. L. Breslow, C. H. Hennekens, J. L. Buring, W. C. Willett, and R. M. Krauss. 1988. Low density lipoprotein subclass patterns and risk of myocardial infarction. J. Am. Med. Assoc. 260: 1917-1921.
15. Austin, M. A., M. C. King, K. M. Vranigan, and R. M. Krauss. 1990. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. circulation. 82: 495-506.
16. Krauss, R. M., J. I. Rotter, and A. J. Lusis, 1995. Genetic and metabolic influences on LDL subclasses. In the Atherosclerosis X. Proceedingsof the 10th International Symposium on Atherosclerosis. Montreal October 9-14, 1994. F. P. Woodford, J. Davignon, and A. Sniderman, editors. Elsevier, Amsterdam. 980-983.
17. McNamara, J. R., H. Campos, J. M. Ordovas, J. Peterson, P. W. F. Wilson, and E. J. Schaefer. 1987. Effects of gender, age and lipid status on low density lipoprotein subfraction distribution. Arteriosclerosis. 7: 483-490.
18. Coresh, J., P. O. Kwiterovich, H. H. Smith, and P. S. Bachorik 1993. Association of plasma triglyceride concentration and LDL particle diameters, density, and chemical composition with premature coronary artery disease in men and women. J. Lipid Res. 34: 1687-1697.
19. Stampfer, M. J., R. M. Krauss, J. Ma, P. J. Blanche, L. G. Holl, F. M. Sacks, and C. H. Hennekens. 1996. A prospective study of trygliceride level, low density lipoprotein particle diameter, and risk of myocardial infarction. J. Am. Med. Assoc. 276: 882-888.
20. Hokanson, J. E., R. M. Krauss, J. J. Albers, M. A. Austin, and J. D. Brunzell. 1995. LDL physical and chemical properties in familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 15: 452-459.
21. Reaven, G. M., Y. D. Chen., J. Jeppesen, P. Maheux, and R. M. Krauss. 1993. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J. Clin. Invest. 92: 141-146.
22. Galeano, N. F., R. Milne, Y. L. Marcel, M. T. Walsh, E. Levy, T. D. Ngu'yen, A. Gleeson, Y. Arad, L. Witte, M. Al-Haideri, S. C. Rumsey, and R. J. Deckelbaum. 1994. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride rich LDL of normal size. J. Biol. Chem. 269: 511-519.
23. McFarlane, A. S. 1958. Efficient trace labelling of proteins with iodine. Nature. 182: 53-57.
24. Bilheimer, D. W., S. Eisenberg, and R. Levy. 1972. The metabolism of very low density lipoprotein proteins in preliminary in vitro and in vivo observations. Biochim. Biophys. Acta. 260: 212-221.
25. Khouw, A. S., S. Parthasarathy, and J. L. Witztum. 1993. Radioiodination of low density lipoprotein initiates lipid peroxidation: protection by use of antioxidants. J. Lipid Res. 34: 1483-1496.
26. Deckelbaum, R. J., S. Eisenberg, Y. Oschry, and L. L. Rudel. 1988. Neutral lipid transfer and lipolysis convert high molecular weight LDL from cholesterol fed nonhuman primates towards normal: a molecular analysis. Biochim. Biophys. Acta. 961: 223-233.
27. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
28. Bartlett, G. R. 1959. Phosphorus assay in column chromatography J. Biol. Chem. 234: 466-488.
29. Buege, J. A., and S. D. Aust. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52: 302-311.
30. Smith, J. B., G. M. Ingerman, and M. J. Silver. 1976. Malondialdehyde formation as an indicator of prostaglandin production by human platelets. J. Lab. Clin. Med. 88: 167-172.
31. Steinbrecher, U. P., J. L. Witztum, S. Parthasarathy, and D. Steinberg. 1987. Decrease in reactive amino groups during oxidation or endothelial cell modification of LDL. Correlation with changes in receptor-mediated catabolism. Arteriosclerosis. 7: 135-143.
32. Tuck, C. H., S. Holleran, and L. Berglund. 1997. Hormone regulation of lipoprotein [a] levels: effects of estrogen replacement therapy on liproprotein[a] and acute phase reactants in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 17: 1822-1829.
33. Pease, R. J., R. W. Milne, W. K. Jessup, A. Law, P. Provost, J. C. Fruchart, R. T. Dean, Y. L. Marcel, and J. Scott. 1990. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B-100. J. Biol. Chem. 265: 553-568.
34. Kesler, G. A., Y. Li, P. J. Skiba, G. M. Fless, and I. Tabas. 1994. Macrophage foam cell lipoprotein [a]/apoprotein[a] receptor. Cell surface localization, dependence of induction in new protein synthesis and ligand specificity. Arterioscler. Thromb. 14: 1337-1345.
35. Görög, P., and J. D. Pearson. 1984. Surface determinants of low density lipoprotein uptake by endothelial cells. Atherosclerosis. 53: 21-29.
36. Williams, J. K., G. M. Fless, K. A. Petrie, M. L. Snyder, R. W. Brocia, and T. L. Swenson. 1992. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein[a], low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and nascent lipoproteins. J. Biol. Chem. 267: 13284-13292.
37. Rumsey, S. C., J. C. Obunike, Y. Arad, R. J. Deckelbaum, and I. J. Goldberg. 1992. Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J. Clin. Invest. 90: 1504-1512.
38. Seo, T., and R. W. St. Clair. 1997. Heparan sulfate proteoglycans mediate internalization and degradation of β-VLDL and promote cholesterol accumulation by pigeon macrophages. J. Lipid Res. 38: 765-779.
39. Eisenberg, S., D. Gavish, Y. Oschry, M. Fainaru, and R. J. Deckelbaum. 1984. Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia. J. Clin. Invest. 74: 470-482.
40. Deckelbaum, R. J., S. Eisenberg, M. Fainaru, Y. Barenholtz, and T. Olivecrona. 1979. In vitro production of human plasma low density lipoprotein-like particles. A model for very low density lipoprotein catabolism. J. Biol. Chem. 254: 6079-6087.
41. Deckelbaum, R. J., T. Olivecrona, and S. Eisenberg. 1984. Plasma lipoproteins in hyperlipidemia: roles of neutral lipid exchange and lipase. In Treatment of Hyperlipoproteinemia. R. A. Carlson and A. G. Olsson, editors. Raven Press, New York. 85-93.
42. Tall, A. T. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
43. Deckelbaum, R. J., S. Eisenberg, Y. Oschry, I. Sharon, E. Butbul, and T. Olivecrona. 1982. Reversible modification of human plasma low density lipoproteins towards triglyceride-rich precursors: a mechanism for losing excess cholesterol esters. J. Biol. Chem. 257: 6509-6517.
44. Chait, A., S. Eisenberg, A. Steinmetz, J. J. Albers, and E. L. Bierman. 1984. Low density lipoproteins modified by lipid transfer protein have altered biological activity. Biochim. Biophys. Acta. 795: 314-324.
45. Hiramatsu, K., E. L. Bierman, and A. Chait. 1985. Metabolism of low density lipoprotein from patients with diabetic hypertriglyceridemia by cultured human skin fibroblasts. Diabetes. 34: 8-14.
46. Aviram, M., S. Lund-Katz, M. C. Phillips, and A. Chait. 1988. The influence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J. Biol. Chem. 263: 16842-16848.
47. La Belle, M., and R. M. Krauss. 1990. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass pattern. J. Lipid Res. 31: 1577-1588.
48. Goldstein, J. L., S. E. Dana, and M. S. Brown. 1974. Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 71: 4288-4292.
49. Attie, A. D., R. C. Pittman, and D. Steinberg. 1980. Metabolism of native and of lactosylated human low density lipoprotein: evidence for two pathways for catabolism of exogenous proteins in rat hepatocytes. Proc. Natl. Acad. Sci. USA. 77: 5923-5927.
50. Basu, S. K., J. L. Goldstein, R. G. W. Anderson, and M. S. Brown. 1976. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 73: 3178-3182.
51. Carew, T. W., M. J. Chapman, S. Goldstein, and D. Steinberg. 1978. Enhanced degradation of trypsin treated low density lipoprotein by fibroblasts from a patient with homozygous familial hypercholesterolemia. Biochim. Biophys. Acta. 529: 171-175.
52. Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1978. Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J. Biol. Chem. 253: 9053-9062.
53. Ji, Z. S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E, enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
54. Al-Haideri, M., I. J. Goldberg, N. F. Galeano, A. Gleeson, T. Vogel, M. Gorecki, S. L. Sturley, and R. J. Deckelbaum. 1997. Heparan sulfate proteoglycan mediated uptake of apolipoprotein E-triglyceride-rich liproprotein particles: a major pathway at physiological partical concentrations. Biochemistry. 36: 12766-12772.
55. Olsson, U., G. Camejo, E. Hurt-Camejo, K. Elfsber, O. Wiklund, and G. Bondjers. 1997. Possible functional interactions of apolipoprotein B-100 segments that associate with cell proteoglycans and the apoB/E receptor. Arterioscler. Thromb. Vasc. Biol. 17: 149-155.
56. Iverius, P. H. 1972. The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. J. Biol. Chem. 247: 2607-2613.
57. Vijanyagopal, P., S. R. Srinivasan, B. Radhakrishnamurthy, and G. S. Berenson. 1983. Hemostatic properties and serum lipoprotein binding of a heparan sulfate proteoglycan from bovine aorta. Biochim. Biophys. Acta. 758: 70-83.
58. Camejo, G. 1982. The interactions of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis. J. Lipid Res. 19: 1-53.
59. Buonassini, V., and P. Colburn. 1983. Antibodies to the heparan sulfate proteoglyans synthesized by endothelial cell cultures. Biochim. Biophys. Acta. 248: 1-12.
60. Keller, R., J. E. Silbert, H. Furthmayer, and J. Modri. 1984. Aortic endothelial cell proteoheparan sulfate. Isolation and characterization of plasma membrane associated and extracellular species. Am. J. Pathol. 128: 286-298.
61. Hiss, D., T. Scott-Burden, and W. Gevers. 1987. Disulfide-bonded heparan sulfate proteoglycans associated with the surfaces of cultured bovine vascular endothelial cells. Eur. J. Biochem. 162: 89-94.
62. Arisaka, T., M. Mitsumata, M. Kawasomi, T. Tohjima, S. Horose, and Y. Yoshida. 1995. Effects of shear stress on glycosaminoglycan synthesis in vascular endothelial cells. Ann. NY Acad. Sci. 748: 543-554.
63. Weisberger, K., and S. C. Rall, Jr. 1987. Human apolipoprotein B-100 heparin-binding sites. J. Biol. Chem. 262: 11097-11103.
64. Cardin, A. D., and H. J. R. Weintraub. 1989. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis. 9: 21-32.
65. Olsson, U., G. Camejo, S. O. Olofsson, and G. Bondjers. 1991. Molecular parameters that control the association of low density lipoprotein apoB-100 with chondroitin sulphate. Biochim Biophys. Acta. 1097: 37-44.
66. Olsson, U., and G. Camejo, G. Bondjers. 1993. Binding of a synthetic apolipoprotein B-100 peptide and peptide analogues to chondroitin 6-sulfate: effects of the lipid environment. Biochemistry. 32: 1858-1865.
67. Hurt-Camejo, E., G. Camejo, B. Rosengren, F. Lopez, O. Wiklund, and V. Bondjers. 1990. Differential uptake of proteoglycan selected subfractions of low density lipoprotein by human macrophages. J. Lipid Res. 31: 1387-1398.
68. Anber, V., J. S. Millar, J. McConnell, J. Shepherd, and C. J. Packard. 1997. Interaction of very low density, intermediate density, and low density lipoproteins with human arterial wall proteoglycans. Arterioscler. Thromb. Vasc. Biol. 17: 2507-2514.
69. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense and atherosclerosis. Structure, binding properties and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 4569-4572.
70. Sakai, J., A. Hishino, S. Takahashi, Y. Miura, H. Ishil, H. Suzuki, Y. Kawarabayasi, and T. Yamamoto. 1994. Structure, chromosome location and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269: 2173-2181.
71. Brown, M. S., J. Herz, R. C. Kowal, and J. L. Goldstein. 1991. The low density lipoprotein receptor related protein: double agent or decoy. Curr. Opin. Lipidol. 2: 65-72.
72. Vasile, E., M. Simionescu, and N. Simionescu. 1983. Visualization of the binding, endocytosis and transcytosis of low density lipoprotein in the arterial endothelium in situ. J. Cell. Biol. 96: 1677-1689.
73. Williams, J. K., and I. Tabas. 1995. The response to retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 351-361.
74. Shepherd, J., M. J. Caslake, A. R. Lorimer, B. D. Vallance, and C. J. Packard. 1985. Fenofibrate reduces low density lipoprotein catabolism in hypertriglyceridemic subjects. Arteriosclerosis. 5: 162-168.
75. Vega, G. L., and S. M. Grundy. 1986. Kinetic heterogenicity of low density lipoproteins in primary hypertriglyceridemia. Arteriosclerosis. 6: 395-406.
76. Nordestgaard, B. G., and D. B. Zilversmit. 1989. Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol fed rabbits. Arteriosclerosis. 9: 176-183.
77. De Graaf, J., H. L. M. Hak-Lammers, M. P. C. Hectors. P. N. M. Demacker, J. C. M. Hendricks, and A. F. H. Stalenhoef. 1991. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler. Thromb. 11: 298-306.
78. Dejager, S., E. Bruckert, and M. F. Chapman. 1993. Dense low density lipoprotein subspecies with diminished oxidative resistance predominated in combined hyperlipidemia. J. Lipid Res. 34: 395-308.
79. Aviram, M., and M. Rosenblat. 1994. Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J. Lipid Res. 35: 385-398.
80. Camejo, G., E. Hurt-Camejo, B. Rosengren, O. Wiklund, F. Lopez, and G. Bondjers. 1991. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycansj. Lipid Res. 32: 1983-1991.
81. Hurt-Camejo, E., G. Camejo, B. Rosengren, F. Lopez, C. Ahlstrom, G. Fager, and G. Bondjers. 1992. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler. Thromb. 12: 569-583.